NADER EL-MALLAWANY to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.245
-
Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
Score: 0.110
-
Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020 08 25; 4(16):4007-4019.
Score: 0.037
-
Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
Score: 0.034
-
Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4).
Score: 0.030
-
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1882-1887.
Score: 0.012
-
Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. BMC Infect Dis. 2020 Apr 25; 20(1):309.
Score: 0.009
-
Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol. 2016 06; 173(5):705-12.
Score: 0.007
-
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.
Score: 0.005